preview

Cure Pharmaceutical Companies

Decent Essays

Pharmaceutical Companies Against A Cure

Through the years rumors have swarmed over the accusations that there is actually a cure for the different types of cancer. However, based on research there seems to be a notable profitable gain within certain pharmaceutical companies, some assume that these companies value money more than offering a permanent cure. Thus making it hard to believe that pharmaceutical companies are in favor of offering medicines that cure certain types of cancer but instead prolong it. This makes pharmaceutical companies feel as if they are operating under a more “Jekyll and Hyde” type of business standard.
Cancer is a wide, and fast spreading illness. “Nearly half of American’s will develop cancer sometime during …show more content…

For example, the B17 vitamin was said to help the cure of cancer but a propaganda was put in place when pharmaceutical companies were unable to gain patent on the product (Higgins).
When thinking in terms of cancer safety one must consider the tobacco industry, which makes billions of dollars from selling major cancer causing products. The Food and Drug Administration is very vocal in public and private sectors to state the health risks associated with tobacco products, and one of which is types of cancer. Furthermore, the government makes additional money from taxes on tobacco products. If there was ever a case where money was going to hide the facts about a product that causes cancer, and the government as well as pharmaceutical companies benefit from it, as then this would be …show more content…

This process of delay by drug companies is called, “evergreening” and once again proves the point that money overrides a person’s quality of life or life in itself. Proven in 2013, pharmaceutical companies actually got the US Supreme Court to allow them to pay these generic drug companies in order to delay the release of certain generic medications for some time, after the patent for medication expires. This allows pharmaceutical companies more time to profit off of their name brand medications (Belk). In fact, pharmaceutical companies paid the FDA around $712 million dollars in 2013 for prescription drugs user fees which in return helped the FDA in the process of approving drugs for sale and distribution in the US

Get Access